ES8801832A1 - Procedimiento para preparar pirrolo-bencimidazoles - Google Patents

Procedimiento para preparar pirrolo-bencimidazoles

Info

Publication number
ES8801832A1
ES8801832A1 ES551002A ES551002A ES8801832A1 ES 8801832 A1 ES8801832 A1 ES 8801832A1 ES 551002 A ES551002 A ES 551002A ES 551002 A ES551002 A ES 551002A ES 8801832 A1 ES8801832 A1 ES 8801832A1
Authority
ES
Spain
Prior art keywords
alkyl
alkenyl
hydroxyl
amino
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES551002A
Other languages
English (en)
Other versions
ES551002A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of ES8801832A1 publication Critical patent/ES8801832A1/es
Publication of ES551002A0 publication Critical patent/ES551002A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

PIRROLO-BENCIMIDAZOLES (I), EN LOS QUE T ES O O S, HET UN HETEROCICLO DE 5 O 6 MIEMBROS, CON HASTA 5 HETEROATOMOS, X ES UNA LINEA DE VALENCIA Y R1 Y R2 RADICALES VARIOS; SE PREPARAN POR REDUCCION DEL GRUPO NITRO EN COMPUESTOS (II) O (III) CON HIDROGENO, MEDIANTE CATALIZADOR DE HIDROGENACION COMO NI RANEY, PY O PD SOBRE CARBON, ENTRE OTROS A TEMPERATURA ENTRE 0 Y 250JC, PREFERIBLEMENTE A TEMPERATURA AMBIENTE, EN UN DISOLVENTE TAL COMO AGUA O ACIDO ACETICO GLACIAL, ENTRE OTROS. DESPUES DE CICLIZA SIN O CON DISOLVENTE, COMO EL ETANOL O SULFULANO ENTRE OTROS, A TEMPERATURA DE EBULLICION DE LA MEZCLA PREFERIBLEMENTE, EVENTUALMENTE EN PRESENCIA DE UN AGENTE DE CONDENSACION COMO OXICLORURO DE FOSFORO Y DE UNA BASE COMO EL HIDROXIDO DE SODIO.
ES551002A 1985-01-18 1986-01-17 Procedimiento para preparar pirrolo-bencimidazoles Expired ES8801832A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853501497 DE3501497A1 (de) 1985-01-18 1985-01-18 Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte

Publications (2)

Publication Number Publication Date
ES8801832A1 true ES8801832A1 (es) 1988-03-01
ES551002A0 ES551002A0 (es) 1988-03-01

Family

ID=6260116

Family Applications (2)

Application Number Title Priority Date Filing Date
ES551002A Expired ES8801832A1 (es) 1985-01-18 1986-01-17 Procedimiento para preparar pirrolo-bencimidazoles
ES557777A Expired ES8900123A1 (es) 1985-01-18 1987-12-09 Procedimiento para preparar pirrolo-bencimidazoles.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES557777A Expired ES8900123A1 (es) 1985-01-18 1987-12-09 Procedimiento para preparar pirrolo-bencimidazoles.

Country Status (15)

Country Link
US (1) US4695567A (es)
EP (1) EP0189103B1 (es)
JP (1) JPS61167689A (es)
AT (1) ATE59649T1 (es)
AU (1) AU580832B2 (es)
DD (1) DD253620A5 (es)
DE (2) DE3501497A1 (es)
DK (1) DK20786A (es)
ES (2) ES8801832A1 (es)
FI (1) FI81579C (es)
GR (1) GR860144B (es)
HU (1) HU194242B (es)
IL (1) IL77582A (es)
SU (1) SU1470191A3 (es)
ZA (1) ZA86360B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3445669A1 (de) * 1984-12-14 1986-06-19 Boehringer Mannheim Gmbh, 6800 Mannheim Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3531678A1 (de) * 1985-09-05 1987-03-12 Boehringer Mannheim Gmbh Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3626664A1 (de) * 1986-08-07 1988-02-11 Boehringer Mannheim Gmbh Tricyclische benzotriazole, verfahren zu ihrer herstellung sowie arzneimittel
DE3639466A1 (de) * 1986-11-18 1988-05-19 Thomae Gmbh Dr K Neue pyrrolo-benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE3642315A1 (de) * 1986-12-11 1988-06-23 Boehringer Mannheim Gmbh Neue pyrrolobenzimidazole, verfahren zu ihrer herstellung sowie arzneimittel
DE3701277A1 (de) * 1987-01-17 1988-07-28 Boehringer Mannheim Gmbh Neue tricyclische benzimidazole, verfahren zu ihrer herstellung und verwendung als arzneimittel
DE3706427A1 (de) * 1987-02-27 1988-09-08 Boehringer Mannheim Gmbh Neue substituierte 3h-indole, zwischenprodukte, verfahren zu ihrer herstellung sowie arzneimittel
DE3740985A1 (de) * 1987-12-03 1989-06-15 Boehringer Mannheim Gmbh Verwendung linear anellierter tricyclen als hemmer der erythrozytenaggregation
US4963677A (en) * 1987-12-30 1990-10-16 Orion Corporation Ltd. Heterocyclic lactam compounds
EP0322746B1 (en) * 1987-12-30 1996-05-29 Orion Corporation Limited Heterocyclic compounds
DE3803775A1 (de) * 1988-02-09 1989-08-17 Boehringer Mannheim Gmbh Neue substituierte lactame, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten
DE3809868A1 (de) * 1988-03-24 1989-10-05 Boehringer Mannheim Gmbh Neue heterocyclisch substituierte 5,7-dihydro-pyrrolo(3,2-f)benzoxazol-6-one, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
DE4027592A1 (de) * 1990-08-31 1992-03-05 Beiersdorf Ag Neue pyrrolobenzimidazole, imidazobenzoxazinone und imidazochinolone, verfahren zu ihrer herstellung und ihre verwendung sowie die verbindungen enthaltende zubereitungen
TW200626149A (en) * 2004-09-24 2006-08-01 Hoffmann La Roche Tricycles, their manufacture and use as pharmaceutical agents
US7285569B2 (en) 2004-09-24 2007-10-23 Hoff Hoffmann-La Roche Inc. Tricycles, their manufacture and use as pharmaceutical agents
US20060142247A1 (en) * 2004-12-17 2006-06-29 Guy Georges Tricyclic heterocycles
BRPI0608178A2 (pt) * 2005-04-14 2009-11-17 Hoffmann La Roche derivados de aminopirazol, sua fabricação, composição farmacêutica e uso como agentes farmacêuticos
US20060235013A1 (en) * 2005-04-14 2006-10-19 Guy Georges Tricyclic azole derivatives
EP1966213A1 (en) * 2005-12-15 2008-09-10 F.Hoffmann-La Roche Ag Tricyclic lactam derivatives, their manufacture and use as pharmaceutical agents
WO2007107346A1 (en) * 2006-03-23 2007-09-27 F. Hoffmann-La Roche Ag Substituted indazole derivatives, their manufacture and use as pharmaceutical agents
MX2015003330A (es) 2012-09-13 2015-06-05 Hoffmann La Roche 2-oxo-2,3-dihidro-indoles para el tratamiento de trastornos del sistema nervioso central (cns).

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN148930B (es) * 1977-09-19 1981-07-25 Hoffmann La Roche
EP0033612B1 (en) * 1980-02-02 1984-04-11 Beecham Group Plc Pyrano derivatives, a process for their preparation and antihypertensive compositions containing them
US4359465A (en) * 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
US4548946A (en) * 1981-03-26 1985-10-22 E. I. Du Pont De Nemours And Company Antiinflammatory and/or analgesic 1,8-Dihydro-(or 3,8-dihydro)-8-aryl-2-[(substituted)thio]-indeno[1,2-d]imidazoles and their corresponding sulfoxides and sulfones
DE3224512A1 (de) * 1982-07-01 1984-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue imidazolderivate, ihre herstellung und diese verbindungen enthaltende arzneimittel
GB8307865D0 (en) * 1983-03-22 1983-04-27 Fujisawa Pharmaceutical Co Benzimidazole derivatives
DE3410168A1 (de) * 1984-03-20 1985-09-26 Boehringer Mannheim Gmbh, 6800 Mannheim Neue isochinolin-dione, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte
PL144822B1 (en) * 1984-05-12 1988-07-30 Boehringer Mannheim Gmbh Method of obtaining novel pyrolobenzimidazoles
US4552876A (en) * 1984-07-09 1985-11-12 Usv Pharmaceutical Corp. Bisbenzoxazines and pharmaceutical use
DE3445669A1 (de) * 1984-12-14 1986-06-19 Boehringer Mannheim Gmbh, 6800 Mannheim Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
HUT41791A (en) 1987-05-28
GR860144B (en) 1986-05-16
FI81579C (fi) 1990-11-12
HU194242B (en) 1988-01-28
DD253620A5 (de) 1988-01-27
EP0189103B1 (de) 1991-01-02
ES8900123A1 (es) 1989-01-16
EP0189103A2 (de) 1986-07-30
IL77582A (en) 1990-01-18
ES551002A0 (es) 1988-03-01
AU580832B2 (en) 1989-02-02
DE3676313D1 (de) 1991-02-07
DK20786A (da) 1986-07-19
DE3501497A1 (de) 1986-07-24
FI860228A (fi) 1986-07-19
ES557777A0 (es) 1989-01-16
FI860228A0 (fi) 1986-01-17
DK20786D0 (da) 1986-01-16
EP0189103A3 (en) 1987-12-23
JPS61167689A (ja) 1986-07-29
ATE59649T1 (de) 1991-01-15
SU1470191A3 (ru) 1989-03-30
FI81579B (fi) 1990-07-31
AU5224586A (en) 1986-07-24
ZA86360B (en) 1986-09-24
US4695567A (en) 1987-09-22

Similar Documents

Publication Publication Date Title
ES8900123A1 (es) Procedimiento para preparar pirrolo-bencimidazoles.
MY101208A (en) Phenyl-piperazine anti-arrhythmia agents.
ATE103915T1 (de) Neue tricyclische benzimidazole, verfahren zu ihrer herstellung und verwendung als arzneimittel.
ES8702409A1 (es) Procedimiento para la preparacion de pirrolo-bencimidazoles
ATE13885T1 (de) Phenylpiperazinderivate von hetarylphenolen und hetarylanilinen, ihre herstellung und diese enthaltende therapeutische mittel.
EP0280224A3 (en) Substituted 3h-indoles, process for their preparation and medicines containing them
ES2262504T3 (es) Derivados del acido piroglutamico y compuestos afines que inhiben la adhesion de leucocitos mediada por la vla-4.
JPS6452719A (en) Heterocyclic sulfide
ES8604960A1 (es) Procedimiento para preparar derivados de 1,6-naftiridina
KR950702544A (ko) 비페닐메탄 유도체 및 이를 함유하는 약제
JPS56103183A (en) Pyridazine derivative and its application to medicine
DK164318C (da) 1-oe3-(2-dialkylaminoethoxy)-2-thienylaa-3-phenyl-1-propanonforbindelser eller syreadditionssalte deraf, fremgangsmaade til fremstilling af saadanne forbindelser samt farmaceutiske praeparater indeholdende disse
IE801761L (en) Pharmaceutical compositions
ATE59650T1 (de) Tricyclische benzotriazole, verfahren zu ihrer herstellung sowie arzneimittel.
SU1441748A1 (ru) 3-(4-бромфенил)-3а,4,6,6а-тетрагидрофуро[3,4-d]изоксазол-4-он, проявляющий противовоспалительную активность